Viewing nowCombinationTwinmax Tablet 80/5 mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.

MFDS item code 201605806 · Approved 2016.09.30 · Insurance code 663607090
Treatment of essential hypertension not controlled with monotherapy
This medication is helpful for patients with essential hypertension whose blood pressure control is insufficient with amlodipine or telmisartan used alone. It effectively lowers blood pressure and reduces the risk of complications due to hypertension. Therefore, it is used in the treatment of essential hypertension.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older patients: The usual amlodipine dosage is recommended for older patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This drug should not be used by patients who are allergic to it, pregnant or breastfeeding, have severely impaired liver or heart function, or certain heart diseases. Patients with mild liver function or gastrointestinal disorders should use this medication with caution. Patients with poor kidney function, the elderly, and those with certain heart conditions should also take it carefully. Patients with severely low blood pressure or in shock, and those unstable after acute myocardial infarction should avoid this medication. Common side effects can include dizziness or peripheral edema; in severe cases, fainting or allergic reactions may occur. Due to blood pressure-lowering effects, caution is advised when driving or operating machinery, and immediate consultation with healthcare providers is required if blood pressure becomes excessively low. This medication may increase the risk of decreased kidney function or hyperkalemia when used in combination with other blood pressure-lowering drugs, so regular blood tests and monitoring of conditions are necessary. It is advisable to avoid taking it with grapefruit juice, as it may enhance the drug's effect. In case of overdose, symptoms like low blood pressure, dizziness, and abnormal heart rhythms may occur, requiring immediate emergency treatment. This medication is not recommended for children, and the elderly must especially have dosage adjustments and careful monitoring.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light. It is essential to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature to preserve the drug's efficacy and safety.
Biconvex oval double-coated tablet in white and light gray
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.